Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815899) titled 'Effects of Peppermint Oil in Pre-metabolic Syndrome' on Sept. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: University of Central Lancashire
Condition:
Pre-metabolic Syndrome
Intervention:
Dietary Supplement: Peppermint Oil
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2025
Target Sample Size: 40
Countries of Recruitment:
United Kingdom
To know more, visit https://clinicaltrials.gov/study/NCT07815899
Published by...